Helmar C. Lehmann

5.6k total citations · 1 hit paper
102 papers, 2.4k citations indexed

About

Helmar C. Lehmann is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Helmar C. Lehmann has authored 102 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Neurology, 41 papers in Cellular and Molecular Neuroscience and 19 papers in Molecular Biology. Recurrent topics in Helmar C. Lehmann's work include Peripheral Neuropathies and Disorders (54 papers), Hereditary Neurological Disorders (32 papers) and Nerve injury and regeneration (13 papers). Helmar C. Lehmann is often cited by papers focused on Peripheral Neuropathies and Disorders (54 papers), Hereditary Neurological Disorders (32 papers) and Nerve injury and regeneration (13 papers). Helmar C. Lehmann collaborates with scholars based in Germany, United States and United Kingdom. Helmar C. Lehmann's co-authors include Bernd C. Kieseier, Satoshi Kuwabara, Nortina Shahrizaila, Hans‐Peter Hartung, Ines Klein, Gerd Meyer zu Hörste, Richard AC Hughes, Gereon R. Fink, Hans‐Peter Hartung and Kazim A. Sheikh and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Helmar C. Lehmann

94 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guillain-Barré syndrome

2021 330 citations Helmar C. Lehmann et al. profile →

Peers

Countries citing papers authored by Helmar C. Lehmann

Since Specialization

Citations

This map shows the geographic impact of Helmar C. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmar C. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmar C. Lehmann more than expected).

Fields of papers citing papers by Helmar C. Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmar C. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmar C. Lehmann. The network helps show where Helmar C. Lehmann may publish in the future.

Co-authorship network of co-authors of Helmar C. Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Helmar C. Lehmann. A scholar is included among the top collaborators of Helmar C. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmar C. Lehmann. Helmar C. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome 2025 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), (unknown), (unknown), Pascal Benkert, (unknown), Anthony Seibert, (unknown), (unknown), Thomas Grüter, (unknown), Barbara Gisevius, Léon Beyer, Klaus Gerwert, Jens Kühle, Michael Schroeter, Helmar C. Lehmann, Ralf Gold, Anna Lena Fisse, Jeremias Motte, Kalliopi Pitarokoili	1
2	Peripheral neuropathy, an independent risk factor for falls in the elderly, impairs stepping as a postural control mechanism: A case‐cohort study 2024 ·Journal of the Peripheral Nervous System ·(unknown), (unknown), (unknown), (unknown), Gilbert Wunderlich, Gereon R. Fink, Jens Peter Klußmann, Michael Schroeter, Helmar C. Lehmann	0
3	Tissue Doppler ultrasound of arm muscles to assess myotonia in myotonic dystrophies: An exploratory study 2024 ·Muscle & Nerve ·(unknown), (unknown), (unknown), Gilbert Wunderlich, Helmar C. Lehmann, Christian Schneider	1
4	Rituximab in non-systemic vasculitic neuropathy: a single-center experience 2024 ·Journal of Neurology ·(unknown), Gilbert Wunderlich, Gereon R. Fink, Michael Schroeter, Helmar C. Lehmann, Christian Schneider	0
5	Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021 2023 ·Eurosurveillance ·Helmar C. Lehmann, Doris Oberle, Brigitte Keller‐Stanislawski, Thorsten Rieck, (unknown)	2
6	Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake 2023 ·Cells ·Ines Klein, Jörg Isensee, Martin H. J. Wiesen, Thomas Imhof, (unknown), Carsten Müller, Tim Hucho, Manuel Koch, Helmar C. Lehmann	8
7	Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy? 2023 ·Therapeutic Advances in Neurological Disorders ·(unknown), Marinos C. Dalakas, Helmar C. Lehmann	7
8	The gut microbiome in intravenous immunoglobulin‐treated chronic inflammatory demyelinating polyneuropathy 2023 ·European Journal of Neurology ·(unknown), (unknown), Anastasia Tsakmaklis, (unknown), Ines Klein, (unknown), Gereon R. Fink, Helmar C. Lehmann, Maria J. G. T. Vehreschild, Fedja Farowski	6
9	Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study 2023 ·European Journal of Neurology ·(unknown), (unknown), Finja Schweitzer, Anne Ladwig, Kalliopi Pitarokoili, David M. Kofler, (unknown), Christian Schneider, (unknown), Ines Klein, (unknown), Helmar C. Lehmann	8
10	Motor unit number estimation by MScanFit in myotonic dystrophies 2023 ·Journal of the Neurological Sciences ·Christian Schneider, (unknown), (unknown), (unknown), Gereon R. Fink, Helmar C. Lehmann	2
11	Glia from the central and peripheral nervous system are differentially affected by paclitaxel chemotherapy via modulating their neuroinflammatory and neuroregenerative properties 2022 ·Frontiers in Pharmacology ·Ines Klein, (unknown), F. de Lange, Britt Christensen, (unknown), Martin H. J. Wiesen, (unknown), Monika Rabenstein, Carsten Müller, Helmar C. Lehmann, Gereon R. Fink, Michael Schroeter, Maria Adele Rueger, Sabine Ulrike Vay	9
12	Exercise and Neuropathy: Systematic Review with Meta-Analysis 2021 ·Sports Medicine ·Fiona Streckmann, Maryam Balke, Guido Cavaletti, (unknown), Wilhelm Bloch, Bernhard F. Décard, Helmar C. Lehmann, Oliver Faude	61
13	Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO 2021 ·Oncology Research and Treatment ·Matthias Zaiß, Jens Uhlig, (unknown), Thomas Decker, Helmar C. Lehmann, (unknown), (unknown), Corinne Vannier, Norbert Marschner	6
14	Meningitis gone viral: description of the echovirus wave 2013 in Germany 2019 ·BMC Infectious Diseases ·Jonas Graf, Christian J. Hartmann, Helmar C. Lehmann, Carolin Otto, Ortwin Adams, Michael Karenfort, Christian Schneider, Klemens Ruprecht, Hans Martin Bosse, Sabine Diedrich, Sindy Böttcher, Alfons Schnitzler, Hans‐Peter Hartung, Orhan Aktaş, Philipp Albrecht	7
15	Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial—VANISH 2019 ·BMJ Open ·Fiona Streckmann, Viviane Hess, Wilhelm Bloch, Bernhard F. Décard, Ramona Ritzmann, Helmar C. Lehmann, Maryam Balke, (unknown), (unknown), Thomas Elter, Lukas Zahner, Lars Donath, Ralf Roth, Oliver Faude	2
16	The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP 2018 ·BMC Cancer ·Fiona Streckmann, Maryam Balke, Helmar C. Lehmann, (unknown), (unknown), Thomas Elter, Michael Hallek, Michael F. Leitzmann, T. Steinmetz, (unknown), Freerk T. Baumann, Wilhelm Bloch	28
17	Posterior Reversible Encephalopathy Syndrome and Stroke after Intravenous Immunoglobulin Treatment in Miller–Fisher Syndrome/Bickerstaff Brain Stem Encephalitis Overlap Syndrome 2014 ·Journal of Stroke and Cerebrovascular Diseases ·Henning Stetefeld, Helmar C. Lehmann, Gereon R. Fink, Lothar Burghaus	22
18	Central nervous system involvement in patients with monoclonal gammopathy and polyneuropathy 2010 ·European Journal of Neurology ·Helmar C. Lehmann, (unknown), Gerd Meyer zu Hörste, H.‐P. Hartung, B. C. Kieseier	4
19	Intravenous immunoglobulins in the treatment of immune neuropathies 2008 ·Current Opinion in Neurology ·Bernd C. Kieseier, Gerd Meyer zu Hörste, Helmar C. Lehmann, Ralf Gold, Hans‐Peter Hartung	10
20	The immunocompetence of Schwann cells 2007 ·Muscle & Nerve ·Gerd Meyer zu Hörste, Wei Hu, Hans‐Peter Hartung, Helmar C. Lehmann, Bernd C. Kieseier	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact